Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00382109 · OUTCOME

Estimated Transplant Related Mortality Percentage

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission · Source last updated 2019-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
100 days

What was measured

Death in a patient who had not relapsed after transplant is defined as transplant-related mortality event.

Analysis population: 2 ineligible patients on experimental arm excluded from analysis.

Groups in this outcome

Experimental

Tacro-MTX/Sirolimus GVHD Prophylaxis

Control

Tacro-MTX GVHD Prophylaxis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Experimental74
Control70

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Experimental13Not reported724Not reported
Control6Not reported215Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7
        upper Limit
        24
        value
        13
      2. group Id
        OG001
        lower Limit
        2
        upper Limit
        15
        value
        6
denoms
  1. counts
    1. group Id
      OG000
      value
      74
    2. group Id
      OG001
      value
      70
    units
    Participants
description
Death in a patient who had not relapsed after transplant is defined as transplant-related mortality event.
dispersion Type
95% Confidence Interval
groups
  1. description
    Tacro-MTX/Sirolimus GVHD Prophylaxis
    id
    OG000
    title
    Experimental
  2. description
    Tacro-MTX GVHD Prophylaxis
    id
    OG001
    title
    Control
param Type
NUMBER
population Description
2 ineligible patients on experimental arm excluded from analysis.
reporting Status
POSTED
time Frame
100 days
title
Estimated Transplant Related Mortality Percentage
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice